The dalteparin sodium market is witnessing steady growth due to the increasing prevalence of cardiovascular diseases, venous thromboembolism (VTE), and other conditions requiring effective anticoagulant therapy. Growing awareness of thrombosis prevention, expanding surgical procedures, and rising demand for low molecular weight heparins (LMWHs) are supporting the adoption of dalteparin sodium...